Rational design of receptor-selective retinoids

Area of Science:

• Dermatology and Pharmacology
• Molecular Biology and Drug Design

Background:

• Systemic retinoids cause adverse effects due to high exposure and poor receptor selectivity.
• Retinoid structure flexibility allows interaction with multiple receptors, potentially leading to off-target effects.
• Improving retinoid selectivity is crucial for minimizing adverse events and enhancing therapeutic efficacy.

Purpose of the Study:

• To investigate if designing more rigid retinoid structures can improve receptor selectivity.
• To enhance the therapeutic index of retinoids by increasing their specificity.
• To develop novel retinoid compounds with improved safety and efficacy profiles.

Main Methods:

• Hypothesized that conformational rigidity enhances retinoid receptor selectivity.
• Designed novel retinoid structures with reduced conformational flexibility.
• Evaluated the receptor binding profiles and therapeutic effects of the developed compounds.

Main Results:

• The rigid structure design strategy led to the development of tazarotene.
• Tazarotene exhibits improved receptor selectivity compared to earlier retinoid generations.
• Topical delivery of tazarotene ensures targeted action on psoriatic keratinocytes.

Conclusions:

• Designing conformationally restricted retinoids can significantly improve receptor selectivity.
• Tazarotene represents a new generation of retinoids with enhanced therapeutic potential.
• Targeted delivery and improved selectivity of tazarotene offer a promising approach for treating psoriasis with reduced side effects.